Pharma News

Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for the development of the Company's lead...

Merck & Co. has consumed Acceleron Pharma, clamorous activist investors notwithstanding.

Neurocrine Biosciences and Sosei Heptares, no strangers to major research pacts, are joining forces for a range of early- to midstage neuro assets. ...

Gilead Sciences has exercised its options, under an agreement signed last year, to obtain exclusive ex-US rights to Arcus Biosciences’ three programmes.

NICE have issued a final appraisal determination (FAD) recommending the use of Inrebic (fedratinib) on the NHS for the treatment of myelofibrosis, a rare blood cancer affecting the bone marrow and ...

About 60 percent of the population is heading into the winter months with reduced protection against the  coronavirus, CDC data shows.

A recent discovery by scientists at the University of Nottingham has found that a plant-based antiviral treatment is effective at treating all variants of the virus SARS-CoV-2. ...

The MHRA has granted marketing authorisation for diroximel fumarate as oral treatment for relapsing-remitting multiple sclerosis.

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration has granted Fast Track Designation for omaveloxolone for the treatment...

On November 17, 2021, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for the adjuvant treatment of patients with renal cell carcinoma (RCC) at intermediate-high or high r...

Novo Nordisk entered into a definitive agreement to acquire Dicerna Pharmaceuticals for $38.25 per share in cash, or a total equity value of around $3.3 billion, the companies said Thursday.  ...

BridgeBio Pharma executed a definitive credit facility agreement with a syndicate of lenders for up to $750M in financing which replaces its $100M debt facility with Hercules.